Neurology

Serum-Leptin and Adiponectin Not Suitable Biomarkers for Multiple Sclerosis

Investigators examined whether serum leptin and adiponectin could be potential biomarkers of disease activity in multiple sclerosis.

Source link




Related posts

CBD Oil Arrives in Texas – Will it live up to expectations?

Newsemia

Balancing reality with hope in epilepsy therapy

Newsemia

Serological evidence of Japanese encephalitis virus circulation in Asian children from dengue-endemic countries.

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy